216
Participants
Start Date
September 30, 2008
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
Placebo
Sildenafil
Duke University Medical Center, Durham
Morehouse School of Medicine, Atlanta
Minnesota Heart Failure Network, Minneapolis
Mayo Clinic, Rochester
Baylor College of Medicine, Houston
University of Utah Health Sciences Center, Murray
Mayo Clinic Arizona, Phoenix
Brigham and Women's Hospital, Boston
University of Vermont - Fletcher Allen Health Care, Burlington
Montreal Heart Institute, Montreal
Lead Sponsor
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Pfizer
INDUSTRY
Duke University
OTHER